Ligand rescue of constitutively active mutant receptors

NeuroSignals

Volumn 11, Issue 1, 2002, Pages 29-33

  Milligan, Graeme ^a,b   Stevens, Patricia A ^a   Ramsay, Douglas ^a   McLean, Alison J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Constitutively active mutant; G protein; Ligand rescue; Receptor; Reporter assay

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ALPRENOLOL; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; DIHYDROALPRENOLOL; GREEN FLUORESCENT PROTEIN; LIGAND; MESSENGER RNA; MUTANT PROTEIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; RECEPTOR; ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; VASOPRESSIN RECEPTOR;

BINDING AFFINITY; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; DRUG EFFICACY; DRUG RECEPTOR BINDING; GLYCOSYLATION; HUMAN; PROTEIN EXPRESSION; REVIEW; ANIMAL; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY;

ANIMALS; GTP-BINDING PROTEINS; HUMANS; LIGANDS; MUTATION; RECEPTORS, ADRENERGIC; RECEPTORS, VASOPRESSIN;

EID: 0036366653     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057319     Document Type: Review

References (30)

1. Lefkowitz RJ, Cotecchia S, Samama P, Costa T: Constitutive activity of receptors coupled to guanine-nucleotide regulatory proteins. Trends Pharmacol Sci 1993;14:303-307.
2. Leurs R, Smit MJ, Alewijnse AE, Timmerman H: Agonist-independent regulation of constitutively active G-protein-coupled receptors. Trends Biochem Sci 1998;23:418-422.
3. de Ligt RA, Kourounakis AP, IJzerman AP: Inverse agonism at G protein-coupled receptors: (Patho)physiological relevance and implications for drug discovery. Br J Pharmacol 2000;130:1-12.
4. 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 1993;268:4625-4636.
5. Chidiac P, Hebert TE, Valiquette M, Dennis M, Bouvier M: Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol 1994;45:490-499.
6. 2-adrenoceptor in transfected neuroblastoma x glioma hybrid cells. Mol Pharmacol 1996;50:1479-1486.
7. Cotecchia S, Exum S, Caron MG, Lefkowitz RJ: Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc Natl Acad Sci USA 1990;87:2896-2900.
8. Allen LF, Lefkowitz RJ, Caron MG, Cotecchia S: G-protein-coupled receptor genes as protooncogenes: Constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci USA 1991;88:11354-11358.
9. Pauwels PJ, Wurch T: Review: Amino acid domains involved in constitutive activation of G-protein-coupled receptors. Mol Neurobiol 1998;17:109-135.
10. Kielsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ: Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 1992;267:1430-1433.
11. Scheer A, Fanelli F, Costa T, De Benedetti PG, Cotecchia S: The activation process of the alpha1B-adrenergic receptor: Potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci USA 1997;94:808-813.
12. Alewijnse AE, Timmerman H, Jacobs EH, Smit MJ, Roovers E, Cotecchia S, Leurs R: The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor. Mol Pharmacol 2000;57:890-898.
13. Scheer A, Costa T, Fanelli F, De Benedetti PG, Mhaouty-Kodja S, Abuin L, Nenniger-Tosato M, Cotecchia S: Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: Effects on receptor isomerization and activation. Mol Pharmacol 2000;57:219-231.
14. Hwa J, Gaivin R, Porter JE, Perez DM: Synergism of constitutive activity in alpha 1-adrenergic receptor activation. Biochemistry 1997;36:633-639.
15. Javitch JA, Fu D, Liapakis G, Chen J: Constitutive activation of the beta2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment. J Biol Chem 1997;272:18546-18549.
16. Samama P, Pei G, Costa T, Cotecchia S, Lefkowitz RJ: Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor. Mol Pharmacol 1994;45:390-394.
17. Rossier O, Abuin L, Fanelli F, Leonardi A, Cotecchia S: Inverse agonism and neutral antagonism at alpha(1a)- and alpha(1b)-adrenergic receptor subtypes. Mol Pharmacol 1999;56:858-866.
18. Pei G, Samama P, Lohse M, Wang M, Codina J, Lefkowitz RJ: A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc Natl Acad Sci USA 1994;91:2699-2702.
19. 1B-adrenoceptor by ligands which act as inverse agonists. Biochem J 1997;325:733-739.
20. Gether U, Ballesteros JA, Seifert R, Sanders-Bush E, Weinstein H, Kobilka BK: Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem 1997;272:2587-2590.
21. 2-adrenoceptor-green fluorescent protein fusion proteins. Mol Pharmacol 1999;56:1182-1191.
22. Morello JP, Salahpour A, Laperriere A, Bernier V, Arthus MF, Lonergan M, Petaja-Repo U, Angers S, Morin D, Bichet DG, Bouvier M: Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 2000;105:887-895.
23. Morello JP, Petaja-Repo UE, Bichet DG, Bouvier M: Pharmacological chaperones: A new twist on receptor folding. Trends Pharmacol Sci 2000;21:466-469.
24. 1b-adrenoceptor. Mol Pharmacol 2000;58:438-448.
25. 2A-adrenergic receptor. Biochemistry 2000;39:693-700.
26. iα-family G protein subtypes. FEBS Lett 1999;462:459-463.
27. Penn RB, Parent JL, Pronin AN, Panettieri RA Jr, Benovic JL: Pharmacological inhibition of protein kinases in intact cells: Antagonism of beta adrenergic receptor ligand binding by H-89 reveals limitations of usefulness. J Pharmacol Exp Ther 1999;288:428-437.
28. Milligan G: Exploring the dynamics of regulation of G protein-coupled receptors using green fluroescent protein. Br J Pharmacol 1999;128:501-510.
29. Kallal L, Benovic JL: Using green fluorescent proteins to study G-protein-coupled receptor localization and trafficking. Trends Pharmacol Sci 2000;21:175-180.
30. Ramsay D, Bevan N, Rees S, Milligan G: Detection of receptor ligands by monitoring selective stabilization of aRenillaluciferase-tagged, constitutively active mutant, G protein-coupled receptor. Br J Pharmacol 2001;133:315-323.